Skip to content

Nature-based Sensory Stimulation on Pain Levels

The Effects of Nature-based Sensory Stimulation on Pain in Women With Fibromyalgia: A Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05017220
Enrollment
42
Registered
2021-08-23
Start date
2021-07-15
Completion date
2021-08-31
Last updated
2021-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Fibromyalgia, Nature-based activities, Pain dimensions, Multisensory stimulation, Quantitative sensory testing

Brief summary

This randomized controlled trial aims to evaluate the effect of a single session intervention based on a nature-based stimulation program in patients with fibromyalgia

Detailed description

All participants will continue to receive their usual pharmacological treatment as previously established by the Andalusian Public Health System. The intervention will comprise interaction tasks with biotic and abiotic agents for 30 minutes.

Interventions

OTHERNature-based sensory stimuli

A program based on stimulation using nature-based sensory stimuli will be implemented

An activity based on a placebo intervention will be implemented

Sponsors

Universidad de Granada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of fibromyalgia syndrome (ACR criteria 2016). * Chronic widespread musculoskeletal pain symptoms (\>1 location using the Widespread Pain Index). * High-intensity pain (VAS ≥ 4), at least 3 days a week for the previous 3 months. * If currently taking analgesic or psychotropic medications, they had to be stabilised for four or more weeks before the study enrolment * Over 18 and less than 65 years old (labour active). * Ability to speak and understand English or Spanish.

Exclusion criteria

* Acute or temporal pain * Severe cognitive impairment, detected by the Mini-Mental State Examination (score \<24 out of 30 points) * Severe mental disorders in acute phase or symptomatic phase * Behavioural alterations as this may interfere in their participation * Severe intellectual disability * Other severe or medically unstable diseases interfering with the project participation * Co-occurrence of neuropathic pain * Other disorders that may cause pain * Pregnant or breast-feeding * Drug abuse within the past year.

Design outcomes

Primary

MeasureTime frameDescription
Pain intensityChange from baseline pain intensity after 30 minutesClinical pain intensity assessed by an 11-points Numeric Rating Scale (NRS-11) ranging from 0 to 10
Cold pain thresholdsChange from baseline cold pain thresholds after 30 minutesCold pressor test will be used
Punctate mechanical hyperalgesiaChange from baseline mechanical hyperalgesia after 30 minutesSemmes-Weinstein monofilament (Aesthesio® Precise Tactile Sensory Evaluator, DanMic Global, LLC, San Jose, CA, USA) calibrated to bend at 300 gm (2940 mN; size 6.65; 0.1143 cm in diameter) of pressure with a response-dependent method will be used
Wind-up phenomenonChange from baseline temporal summation of pain perception after 30 minutesWind-up is a frequency- and intensity-dependent increase in the excitability of dorsal horn neuron that results in a temporal summation of pain perception.
Pressure pain thresholdsChange from baseline pressure pain thresholds after 30 minutesThe minimum pressure force which induces pain when pressure is applied on tissues is regarded as the pressure pain threshold

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026